CVS Health (NYSE: CVS) reported Q4 EPS of $2.14, $0.09 better than the analyst estimate of $2.05. Revenue for the quarter came in at $54.4 billion versus the consensus estimate of $54.58 billion.

GUIDANCE:

CVS Health sees FY2019 EPS of $6.68-$6.88, versus the consensus of $7.41.

For earnings history and earnings-related data on CVS Health (CVS) click here.